401k Plan data: ARNET PHARMACEUTICAL CORP 401K plan

ARNET PHARMACEUTICAL CORP 401K 401k Plan overview

Plan Name	ARNET PHARMACEUTICAL CORP 401K
Plan identification number	001

ARNET PHARMACEUTICAL CORP 401K Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

ARNET PHARMACEUTICAL CORP has sponsored the creation of one or more 401k plans.

Company Name: ARNET PHARMACEUTICAL CORP

Employer identification number (EIN): 650391750

NAIC Classification: 541990
NAIC Description: All Other Professional, Scientific, and Technical Services

Form 5500 Filing Information

Submission information for form 5500 for 401k plan ARNET PHARMACEUTICAL CORP 401K

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2021-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2018-01-01
001 2017-01-01 ADAM FRIEDMAN ADAM FRIEDMAN 2018-08-14
001 2016-01-01 ADAM FRIEDMAN
001 2016-01-01
001 2016-01-01

Plan Statistics for ARNET PHARMACEUTICAL CORP 401K

401k plan membership statisitcs for ARNET PHARMACEUTICAL CORP 401K

Measure Date Value
2022: ARNET PHARMACEUTICAL CORP 401K 2022 401k membership
Total participants, beginning-of-year 2022-01-01 341
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 344
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 22
Total of all active and inactive participants 2022-01-01 366
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 366
Number of participants with account balances 2022-01-01 185
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 15
2021: ARNET PHARMACEUTICAL CORP 401K 2021 401k membership
Total participants, beginning-of-year 2021-01-01 282
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 305
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 18
Total of all active and inactive participants 2021-01-01 323
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 323
Number of participants with account balances 2021-01-01 147
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 7
2020: ARNET PHARMACEUTICAL CORP 401K 2020 401k membership
Total participants, beginning-of-year 2020-01-01 314
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 264
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 11
Total of all active and inactive participants 2020-01-01 275
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 275
Number of participants with account balances 2020-01-01 134
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 7
2019: ARNET PHARMACEUTICAL CORP 401K 2019 401k membership
Total participants, beginning-of-year 2019-01-01 308
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 298
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 15
Total of all active and inactive participants 2019-01-01 313
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 313
Number of participants with account balances 2019-01-01 140
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 10
2018: ARNET PHARMACEUTICAL CORP 401K 2018 401k membership
Total participants, beginning-of-year 2018-01-01 295
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 269
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 33
Total of all active and inactive participants 2018-01-01 302
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 302
Number of participants with account balances 2018-01-01 155
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 11
2017: ARNET PHARMACEUTICAL CORP 401K 2017 401k membership
Total participants, beginning-of-year 2017-01-01 316
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 278
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 14
Total of all active and inactive participants 2017-01-01 292
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 292
Number of participants with account balances 2017-01-01 103
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 4
2016: ARNET PHARMACEUTICAL CORP 401K 2016 401k membership
Total participants, beginning-of-year 2016-01-01 318
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 300
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 10
Total of all active and inactive participants 2016-01-01 310
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 310
Number of participants with account balances 2016-01-01 99
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 7

Measure	Date	Value
2022: ARNET PHARMACEUTICAL CORP 401K 2022 401k membership
Total participants, beginning-of-year	2022-01-01	341
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	344
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	22
Total of all active and inactive participants	2022-01-01	366
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	366
Number of participants with account balances	2022-01-01	185
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	15
2021: ARNET PHARMACEUTICAL CORP 401K 2021 401k membership
Total participants, beginning-of-year	2021-01-01	282
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	305
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	18
Total of all active and inactive participants	2021-01-01	323
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	323
Number of participants with account balances	2021-01-01	147
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	7
2020: ARNET PHARMACEUTICAL CORP 401K 2020 401k membership
Total participants, beginning-of-year	2020-01-01	314
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	264
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	11
Total of all active and inactive participants	2020-01-01	275
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	275
Number of participants with account balances	2020-01-01	134
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	7
2019: ARNET PHARMACEUTICAL CORP 401K 2019 401k membership
Total participants, beginning-of-year	2019-01-01	308
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	298
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	15
Total of all active and inactive participants	2019-01-01	313
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	313
Number of participants with account balances	2019-01-01	140
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	10
2018: ARNET PHARMACEUTICAL CORP 401K 2018 401k membership
Total participants, beginning-of-year	2018-01-01	295
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	269
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	33
Total of all active and inactive participants	2018-01-01	302
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	302
Number of participants with account balances	2018-01-01	155
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	11
2017: ARNET PHARMACEUTICAL CORP 401K 2017 401k membership
Total participants, beginning-of-year	2017-01-01	316
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	278
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	14
Total of all active and inactive participants	2017-01-01	292
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	292
Number of participants with account balances	2017-01-01	103
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	4
2016: ARNET PHARMACEUTICAL CORP 401K 2016 401k membership
Total participants, beginning-of-year	2016-01-01	318
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	300
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	10
Total of all active and inactive participants	2016-01-01	310
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	310
Number of participants with account balances	2016-01-01	99
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	7

Financial Data on ARNET PHARMACEUTICAL CORP 401K

Measure	Date	Value
2022 : ARNET PHARMACEUTICAL CORP 401K 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total transfer of assets to this plan	2022-12-31	$0
Total transfer of assets from this plan	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$0
Total income from all sources (including contributions)	2022-12-31	$292,498
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$197,983
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$193,294
Expenses. Certain deemed distributions of participant loans	2022-12-31	$986
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$605,780
Value of total assets at end of year	2022-12-31	$1,775,686
Value of total assets at beginning of year	2022-12-31	$1,681,171
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$3,703
Total interest from all sources	2022-12-31	$2,458
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$112,700
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$112,700
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$169,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$381,274
Participant contributions at end of year	2022-12-31	$51,005
Participant contributions at beginning of year	2022-12-31	$50,512
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$16,702
Administrative expenses (other) incurred	2022-12-31	$3,703
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$94,515
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$1,775,686
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$1,681,171
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$1,503,006
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$1,440,253
Interest on participant loans	2022-12-31	$2,458
Value of interest in common/collective trusts at end of year	2022-12-31	$221,675
Value of interest in common/collective trusts at beginning of year	2022-12-31	$190,406
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-391,595
Net investment gain or loss from common/collective trusts	2022-12-31	$-36,845
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	No
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$207,804
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$193,294
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	TEMPLETON & CO
Accountancy firm EIN	2022-12-31	141918990
2021 : ARNET PHARMACEUTICAL CORP 401K 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total transfer of assets to this plan	2021-12-31	$0
Total transfer of assets from this plan	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$631,398
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$207,005
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$197,135
Expenses. Certain deemed distributions of participant loans	2021-12-31	$7,122
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$429,508
Value of total assets at end of year	2021-12-31	$1,681,171
Value of total assets at beginning of year	2021-12-31	$1,256,778
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$2,748
Total interest from all sources	2021-12-31	$2,943
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$176,033
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$176,033
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$126,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$295,499
Participant contributions at end of year	2021-12-31	$50,512
Participant contributions at beginning of year	2021-12-31	$53,851
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$29,607
Administrative expenses (other) incurred	2021-12-31	$2,748
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$424,393
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$1,681,171
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$1,256,778
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$1,440,253
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$1,074,673
Interest on participant loans	2021-12-31	$2,943
Value of interest in common/collective trusts at end of year	2021-12-31	$190,406
Value of interest in common/collective trusts at beginning of year	2021-12-31	$128,254
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$-15,465
Net investment gain or loss from common/collective trusts	2021-12-31	$38,379
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$104,402
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$197,135
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	TEMPLETON & CO
Accountancy firm EIN	2021-12-31	141918990
2020 : ARNET PHARMACEUTICAL CORP 401K 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total transfer of assets from this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$510,186
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$275,857
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$272,101
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$360,280
Value of total assets at end of year	2020-12-31	$1,256,778
Value of total assets at beginning of year	2020-12-31	$1,022,449
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$3,756
Total interest from all sources	2020-12-31	$2,799
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$42,807
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$42,807
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$103,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$263,780
Participant contributions at end of year	2020-12-31	$53,851
Participant contributions at beginning of year	2020-12-31	$36,615
Administrative expenses (other) incurred	2020-12-31	$3,756
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$234,329
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$1,256,778
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$1,022,449
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$1,074,673
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$924,928
Interest on participant loans	2020-12-31	$2,799
Value of interest in common/collective trusts at end of year	2020-12-31	$128,254
Value of interest in common/collective trusts at beginning of year	2020-12-31	$60,906
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$86,059
Net investment gain or loss from common/collective trusts	2020-12-31	$18,241
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$96,500
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$272,101
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	TEMPLETON & CO
Accountancy firm EIN	2020-12-31	141918990
2019 : ARNET PHARMACEUTICAL CORP 401K 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total transfer of assets from this plan	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$570,105
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$172,880
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$169,257
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$415,200
Value of total assets at end of year	2019-12-31	$1,022,449
Value of total assets at beginning of year	2019-12-31	$625,224
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$3,623
Total interest from all sources	2019-12-31	$2,481
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$92,400
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$92,400
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$63,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$239,370
Participant contributions at end of year	2019-12-31	$36,615
Participant contributions at beginning of year	2019-12-31	$23,295
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$86,659
Administrative expenses (other) incurred	2019-12-31	$3,623
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$397,225
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$1,022,449
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$625,224
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$924,928
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$570,992
Interest on participant loans	2019-12-31	$2,481
Value of interest in common/collective trusts at end of year	2019-12-31	$60,906
Value of interest in common/collective trusts at beginning of year	2019-12-31	$30,937
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$48,943
Net investment gain or loss from common/collective trusts	2019-12-31	$11,081
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$89,171
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$169,257
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	TEMPLETON & CO
Accountancy firm EIN	2019-12-31	141918990
2018 : ARNET PHARMACEUTICAL CORP 401K 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total transfer of assets to this plan	2018-12-31	$0
Total transfer of assets from this plan	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$290,158
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$53,445
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$41,367
Value of total corrective distributions	2018-12-31	$12,078
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$343,958
Value of total assets at end of year	2018-12-31	$625,224
Value of total assets at beginning of year	2018-12-31	$388,511
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$0
Total interest from all sources	2018-12-31	$711
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$29,259
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$29,259
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$39,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$247,757
Participant contributions at end of year	2018-12-31	$23,295
Participant contributions at beginning of year	2018-12-31	$8,313
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$10,521
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$236,713
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$625,224
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$388,511
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$570,992
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$376,081
Interest on participant loans	2018-12-31	$711
Value of interest in common/collective trusts at end of year	2018-12-31	$30,937
Value of interest in common/collective trusts at beginning of year	2018-12-31	$4,117
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-81,293
Net investment gain or loss from common/collective trusts	2018-12-31	$-2,477
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$85,680
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$41,367
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	TEMPLETON & CO
Accountancy firm EIN	2018-12-31	141918990
2017 : ARNET PHARMACEUTICAL CORP 401K 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets to this plan	2017-12-31	$0
Total transfer of assets from this plan	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$242,433
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$17,833
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$17,183
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$198,479
Value of total assets at end of year	2017-12-31	$388,511
Value of total assets at beginning of year	2017-12-31	$163,911
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$650
Total interest from all sources	2017-12-31	$154
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$12,781
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$12,781
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$17,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$166,060
Participant contributions at end of year	2017-12-31	$8,313
Participant contributions at beginning of year	2017-12-31	$1,650
Administrative expenses (other) incurred	2017-12-31	$650
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$224,600
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$388,511
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$163,911
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$376,081
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$160,867
Interest on participant loans	2017-12-31	$154
Value of interest in common/collective trusts at end of year	2017-12-31	$4,117
Value of interest in common/collective trusts at beginning of year	2017-12-31	$1,394
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$30,569
Net investment gain or loss from common/collective trusts	2017-12-31	$450
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$32,419
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$17,183
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	TEMPLETON & CO
Accountancy firm EIN	2017-12-31	141918990
2016 : ARNET PHARMACEUTICAL CORP 401K 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total transfer of assets to this plan	2016-12-31	$0
Total transfer of assets from this plan	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$166,665
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$2,754
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$2,219
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$162,453
Value of total assets at end of year	2016-12-31	$163,911
Value of total assets at beginning of year	2016-12-31	$0
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$535
Total interest from all sources	2016-12-31	$0
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$3,215
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$3,215
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$1,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$136,004
Participant contributions at end of year	2016-12-31	$1,650
Administrative expenses (other) incurred	2016-12-31	$535
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$163,911
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$163,911
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$0
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$160,867
Value of interest in common/collective trusts at end of year	2016-12-31	$1,394
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$913
Net investment gain or loss from common/collective trusts	2016-12-31	$84
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$26,449
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$2,219
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	TEMPLETON & CO
Accountancy firm EIN	2016-12-31	141918990

Form 5500 Responses for ARNET PHARMACEUTICAL CORP 401K

2022: ARNET PHARMACEUTICAL CORP 401K 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: ARNET PHARMACEUTICAL CORP 401K 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: ARNET PHARMACEUTICAL CORP 401K 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: ARNET PHARMACEUTICAL CORP 401K 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: ARNET PHARMACEUTICAL CORP 401K 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	Yes
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: ARNET PHARMACEUTICAL CORP 401K 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: ARNET PHARMACEUTICAL CORP 401K 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	First time form 5500 has been submitted	Yes
2016-01-01	Submission has been amended	Yes
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	ARNET PHARMACEUTICAL CORP
Employer identification number (EIN):	650391750
NAIC Classification:	541990
NAIC Description:	All Other Professional, Scientific, and Technical Services